두경부암의 수술적 치료

한명월¹^,^*

Surgical Treatment of Head and Neck Cancer

Myung Woul Han¹^,^*

¹울산대학교 의과대학 이비인후과학교실

¹Department of Otolaryngology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea

^*Corresponding Author : MyungWoul Han, MD, PhD, Department of Otolaryngology, Ulsan University Hospital, University of Ulsan College of Medicine, 877 Bangeojinsunhwan-doro, Dong-gu, Ulsan 44033, Korea, Tel: +82-52-250-8922, Fax: +82-52-250-7182, E-mail: brightmoon@uuh.ulsan.kr

ⓒ Copyright 2018 Korean Society of Lymphology and Lymphedema. This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Received: Apr 23, 2018; Accepted: May 08, 2018

Published Online: May 31, 2018

Abatract

Chemoradiation therapy has become increasingly popular in the treatment of head and neck cancer as part of an organ preservation protocol. However, surgical management including neck dissection has the important role in treatment of head and neck cancer, especially advanced cancer. Lymphedema is a frequent side effect from head and neck cancer and/or its treatment. A early identification and timely appropriate therapy of head and neck lymphedema is critical to improve clinical outcomes and decrease symptom burden, functional impairments, and improve overall quality of life in head and neck cancer patients.

Keywords: Head and neck cancer; Lymphedema; Surgery; Neck dissection